Skip Nav Destination
Close Modal
Update search
NARROW
Date
Availability
1-20 of 601
Review Articles
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
1
Sort by
Journal Articles
Immunoactinopathies revisited: understanding clinical manifestations and biological pathways
Available to Purchase
Journal:
Blood
Blood (2025) 145 (23): 2709–2732.
Published: 2025
Includes: Supplemental data
Journal Articles
Precision medicine for high-risk gene fusions in pediatric AML: a focus on KMT2A , NUP98 , and GLIS2 rearrangements
Available to Purchase
Journal:
Blood
Blood (2025) 145 (22): 2574–2586.
Published: 2025
Journal Articles
Advances in RNA editing in hematopoiesis and associated malignancies
Available to Purchase
Journal:
Blood
Blood (2025) 145 (21): 2424–2438.
Published: 2025
Journal Articles
EMZL at various sites: learning from each other
Available to Purchase
Journal:
Blood
Blood (2025) 145 (19): 2117–2127.
Published: 2025
Journal Articles
Genetic subtypes of B-cell acute lymphoblastic leukemia in adults
Available to Purchase
Journal:
Blood
Blood (2025) 145 (14): 1451–1463.
Published: 2025
Journal Articles
Incorporation of immunotherapy into frontline treatment for adults with B-cell precursor acute lymphoblastic leukemia
Available to Purchase
Journal:
Blood
Blood (2025) 145 (14): 1475–1484.
Published: 2025
Journal Articles
The present and future of CAR T-cell therapy for adult B-cell ALL
Available to Purchase
Journal:
Blood
Blood (2025) 145 (14): 1485–1497.
Published: 2025
Journal Articles
Classification and risk stratification in T-lineage acute lymphoblastic leukemia
Available to Purchase
Journal:
Blood
Blood (2025) 145 (14): 1464–1474.
Published: 2025
Journal Articles
Honing CAR T cells to tackle acute myeloid leukemia
Available to Purchase
Journal:
Blood
Blood (2025) 145 (11): 1113–1125.
Published: 2025
Journal Articles
The contribution of the monocyte-macrophage lineage to immunotherapy outcomes
Available to Purchase
Journal:
Blood
Blood (2025) 145 (10): 1010–1021.
Published: 2025
Journal Articles
The evolution of treatment-free remission
Available to Purchase
Journal:
Blood
Blood (2025) 145 (9): 921–930.
Published: 2025
Journal Articles
Novel treatment strategies for chronic myeloid leukemia
Available to Purchase
Journal:
Blood
Blood (2025) 145 (9): 931–943.
Published: 2025
Journal Articles
Long-term outcomes of tyrosine kinase inhibitors in chronic myeloid leukemia
Available to Purchase
Journal:
Blood
Blood (2025) 145 (9): 910–920.
Published: 2025
Journal Articles
High-risk MCL: recognition and treatment
Available to Purchase
Journal:
Blood
Blood (2025) 145 (7): 683–695.
Published: 2025
Includes: Supplemental data
Journal Articles
Frontline management of mantle cell lymphoma
Available to Purchase
Journal:
Blood
Blood (2025) 145 (7): 663–672.
Published: 2025
Journal Articles
Unraveling MCL biology to understand resistance and identify vulnerabilities
Available to Purchase
Journal:
Blood
Blood (2025) 145 (7): 696–707.
Published: 2025
Journal Articles
Treatment of relapsed/refractory MCL
Available to Purchase
Clinical Trials & Observations
Journal:
Blood
Blood (2025) 145 (7): 673–682.
Published: 2025
Journal Articles
Genetic and clinical spectrum of SAMD9 and SAMD9L syndromes: from variant interpretation to patient management
Available to Purchase
Journal:
Blood
Blood (2025) 145 (5): 475–485.
Published: 2025
Includes: Supplemental data
Journal Articles
Management of iron overload: lessons from transfusion-dependent hemoglobinopathies
Available to Purchase
Journal:
Blood
Blood (2025) 145 (4): 359–371.
Published: 2025
Includes: Supplemental data
Journal Articles
Current myeloproliferative neoplasm scoring systems for clinical practice
Available to Purchase
Journal:
Blood
Blood (2025) 145 (3): 257–276.
Published: 2025
1
Advertisement intended for health care professionals